Ashley E Walker1,2, Elise K Kronquist1, Kerrick T Chinen1, Kelly D Reihl2, Dean Y Li2,3,4,5,6,7, Lisa A Lesniewski2,8,9, Anthony J Donato2,8,9. 1. Department of Human Physiology, University of Oregon, Eugene, OR, USA. 2. Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA. 3. Program in Molecular Medicine, University of Utah, Salt Lake City, UT, USA. 4. Department of Human Genetics, University of Utah, Salt Lake City, UT, USA. 5. Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA. 6. The Key Laboratory for Human Disease Gene Study of Sichuan Province, Institute of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, Sichuan, China. 7. Department of Cardiology, Veteran's Affairs Medical Center, Salt Lake City, UT, USA. 8. Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, UT, USA. 9. Geriatrics Research Education and Clinical Center, Veteran's Affairs Medical Center, Salt Lake City, UT, USA.
Abstract
NEW FINDINGS: What is the central question of this study? Greater large artery stiffness is associated with dysfunctional resistance artery vasodilatory responses, impaired memory and greater risk of Alzheimer's disease. However, it is unknown whether stiffer large arteries affect cerebral and skeletal muscle feed artery responses to vasoconstrictors. What is the main finding and its importance? In a mouse model with greater large artery stiffness (Eln+/- ), we find an exacerbated vasoconstrictor response to angiotensin II in cerebral arteries, but not skeletal muscle feed arteries, thus implicating altered cerebral artery angiotensin II responsiveness in the poor brain outcomes associated with greater large artery stiffness. ABSTRACT: Greater stiffness of the large elastic arteries is associated with end-organ damage and dysfunction. At the same time, resistance artery vasoconstrictor responsiveness influences vascular tone and organ blood flow. However, it is unknown whether large elastic artery stiffness modulates the responsiveness to vasoconstrictors in resistance arteries of the cerebral or skeletal muscle circulations. We previously described the elastin haploinsufficient (Eln+/- ) mouse as a model with greater aortic stiffness, but with similar cerebral and skeletal muscle feed artery stiffness to wild-type (Eln+/+ ) mice. Here, we used this model to examine the relationship between large elastic artery stiffness and resistance artery vasoconstrictor responses. In middle cerebral arteries (MCAs), vasoconstriction in response to angiotensin II (Ang II) was ∼40% greater in Eln+/- compared with Eln+/+ mice (P = 0.02), and this group difference was ameliorated by losartan, indicating a role for Ang II type 1 receptors (AT1Rs). In gastrocnemius feed arteries, Eln+/- and Eln+/+ mice did not differ in the response to Ang II. In addition, the vasoconstrictor responses to noradrenaline, endothelin-1 and potassium chloride were not different between Eln+/- and Eln+/+ mice for either MCAs or gastrocnemius feed arteries. The MCA AT1R gene expression did not differ between groups, whereas Ang II type 2 receptor gene expression was ∼50% lower in MCAs from Eln+/- versus Eln+/+ mice (P = 0.01). In conclusion, greater large elastic artery stiffness is associated with an exacerbated vasoconstriction response to Ang II in cerebral arteries, but is not associated with the responses to other vasoconstrictors in either cerebral or skeletal muscle feed arteries.
NEW FINDINGS: What is the central question of this study? Greater large artery stiffness is associated with dysfunctional resistance artery vasodilatory responses, impaired memory and greater risk of Alzheimer's disease. However, it is unknown whether stiffer large arteries affect cerebral and skeletal muscle feed artery responses to vasoconstrictors. What is the main finding and its importance? In a mouse model with greater large artery stiffness (Eln+/- ), we find an exacerbated vasoconstrictor response to angiotensin II in cerebral arteries, but not skeletal muscle feed arteries, thus implicating altered cerebral artery angiotensin II responsiveness in the poor brain outcomes associated with greater large artery stiffness. ABSTRACT: Greater stiffness of the large elastic arteries is associated with end-organ damage and dysfunction. At the same time, resistance artery vasoconstrictor responsiveness influences vascular tone and organ blood flow. However, it is unknown whether large elastic artery stiffness modulates the responsiveness to vasoconstrictors in resistance arteries of the cerebral or skeletal muscle circulations. We previously described the elastinhaploinsufficient (Eln+/- ) mouse as a model with greater aortic stiffness, but with similar cerebral and skeletal muscle feed artery stiffness to wild-type (Eln+/+ ) mice. Here, we used this model to examine the relationship between large elastic artery stiffness and resistance artery vasoconstrictor responses. In middle cerebral arteries (MCAs), vasoconstriction in response to angiotensin II (Ang II) was ∼40% greater in Eln+/- compared with Eln+/+ mice (P = 0.02), and this group difference was ameliorated by losartan, indicating a role for Ang II type 1 receptors (AT1Rs). In gastrocnemius feed arteries, Eln+/- and Eln+/+ mice did not differ in the response to Ang II. In addition, the vasoconstrictor responses to noradrenaline, endothelin-1 and potassium chloride were not different between Eln+/- and Eln+/+ mice for either MCAs or gastrocnemius feed arteries. The MCAAT1R gene expression did not differ between groups, whereas Ang II type 2 receptor gene expression was ∼50% lower in MCAs from Eln+/- versus Eln+/+ mice (P = 0.01). In conclusion, greater large elastic artery stiffness is associated with an exacerbated vasoconstriction response to Ang II in cerebral arteries, but is not associated with the responses to other vasoconstrictors in either cerebral or skeletal muscle feed arteries.
Authors: Anthony J Donato; Lisa A Lesniewski; Deborah Stuart; Ashley E Walker; Grant Henson; Lise Sorensen; Dean Li; Donald E Kohan Journal: Life Sci Date: 2014-01-08 Impact factor: 5.037
Authors: Jessica E Wagenseil; Nandan L Nerurkar; Russell H Knutsen; Ruth J Okamoto; Dean Y Li; Robert P Mecham Journal: Am J Physiol Heart Circ Physiol Date: 2005-04-29 Impact factor: 4.733
Authors: Gary F Mitchell; Joseph A Vita; Martin G Larson; Helen Parise; Michelle J Keyes; Elaine Warner; Ramachandran S Vasan; Daniel Levy; Emelia J Benjamin Journal: Circulation Date: 2005-12-05 Impact factor: 29.690
Authors: Jessica E Wagenseil; Russell H Knutsen; Dean Y Li; Robert P Mecham Journal: Am J Physiol Heart Circ Physiol Date: 2007-03-30 Impact factor: 4.733
Authors: Gary P Van Guilder; Christian M Westby; Jared J Greiner; Brian L Stauffer; Christopher A DeSouza Journal: Hypertension Date: 2007-06-18 Impact factor: 10.190
Authors: Anthony J Donato; Ashley E Walker; Katherine A Magerko; R Colton Bramwell; Alex D Black; Grant D Henson; Brooke R Lawson; Lisa A Lesniewski; Douglas R Seals Journal: Aging Cell Date: 2013-07-02 Impact factor: 9.304
Authors: Zachary Barrett-O'Keefe; Melissa A H Witman; John McDaniel; Anette S Fjeldstad; Joel D Trinity; Stephen J Ives; Jamie D Conklin; Van Reese; Sean Runnels; David E Morgan; Mikael Sander; Russell S Richardson; D Walter Wray Journal: Clin Sci (Lond) Date: 2013-03 Impact factor: 6.124
Authors: Mylène Pezet; Marie-Paule Jacob; Brigitte Escoubet; Dealba Gheduzzi; Emmanuelle Tillet; Pascale Perret; Philippe Huber; Daniela Quaglino; Roger Vranckx; Dean Y Li; Barry Starcher; Walter A Boyle; Robert P Mecham; Gilles Faury Journal: Rejuvenation Res Date: 2008-02 Impact factor: 4.663
Authors: Fatima Y Noureddine; Raffaele Altara; Fan Fan; Andriy Yabluchanskiy; George W Booz; Fouad A Zouein Journal: Int J Mol Sci Date: 2020-06-16 Impact factor: 5.923
Authors: Angela Troia; Russell H Knutsen; Carmen M Halabi; Daniela Malide; Zu Xi Yu; Amanda Wardlaw-Pickett; Elise K Kronquist; Kit Man Tsang; Attila Kovacs; Robert P Mecham; Beth A Kozel Journal: Function (Oxf) Date: 2021-03-15